Abeona Therapeutics Achieves Target Enrollment in Pivotal Phase 3 VIITAL™ Study of EB-101 in RDEB Mar 14, 2022
Abeona Therapeutics Announces Support of EB Research Partnership's Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa Nov 18, 2021
Abeona Therapeutics Announces Presentation on Pivotal Transpher A Study of ABO-102 in MPS IIIA at the 14th ICIEM Conference Nov 17, 2021
Abeona Therapeutics Announces Participation at the Jefferies London Healthcare Conference Nov 16, 2021
Abeona Therapeutics Announces Clinical Data Presentations at Upcoming Scientific Congresses Oct 13, 2021
